Company Filing History:
Years Active: 2015
Title: Innovations by Kasper Huus in Pharmaceutical Formulations
Introduction
Kasper Huus is a notable inventor based in København V, Denmark. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of insulin derivatives. His innovative work has led to the creation of a unique formulation that enhances the efficacy of insulin treatments.
Latest Patents
Kasper Huus holds 1 patent for his invention titled "Pharmaceutical formulations comprising an insulin derivative." This invention focuses on a soluble pharmaceutical formulation that includes an insulin derivative, which is enhanced by the presence of more than 4 zinc atoms per 6 molecules of the insulin derivative. Additionally, the formulation incorporates citric acid monohydrate and/or a histidine compound, which increases the tendency of the insulin derivative to self-associate into dodecamers. The patent also outlines a process for preparing this soluble pharmaceutical formulation.
Career Highlights
Kasper Huus is associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care and other chronic conditions. His work at Novo Nordisk has allowed him to contribute to advancements in diabetes treatment through innovative pharmaceutical solutions.
Collaborations
Kasper has collaborated with notable colleagues such as Christian Poulsen and Frantisek Hubalek. These collaborations have fostered a productive environment for innovation and development in the pharmaceutical sector.
Conclusion
Kasper Huus's contributions to pharmaceutical formulations, particularly in the area of insulin derivatives, highlight his role as an influential inventor in the healthcare industry. His innovative approaches continue to pave the way for advancements in diabetes treatment.